InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Explore the detailed record of transactions filed by Gerberding Julie L., Director. Officer active across 2 companies, notably CERNER Corp. Cumulatively, 6 reports have been published. The latest transaction was filed on 7 June 2022 — U. Regulator: SEC (Form 4). All data is openly available.
Declarations6 total
€1m15,032 shares@ €88.7965100.0% of flow
Common Stock
SEC:0001209191-22-035497:0·
€620,9449,550 shares@ €65.02030.0002% mcap100.0% of flow
Common Stock
SEC:0001127602-22-007008:0·
035,287 shares0
Common Stock
SEC:0001127602-21-028263·
035,287 shares0
Common Stock
SEC:0001127602-21-028263:0·
03,188 shares0
Common Stock
SEC:0001209191-21-034517·
03,188 shares0
Common Stock
SEC:0001209191-21-034517:0·
6 of 6 declarations
About Gerberding Julie L.
Julie L. Gerberding is a Board Member and Executive Vice President, Chief Patient Officer at CERNER Corp and Merck & Co., Inc. She plays a key role in the governance of these companies, bringing her expertise in health and management. Her involvement in the boards allows her to contribute to strategic decision-making and guide the companies toward a sustainable future.
